PubMed
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
Davalos et al., 2012
Neurological & CognitiveSupplement / Drug (region-dependent)C
CDP-Choline
Citicoline
Choline donor and nootropic compound used for cognitive and neuro-support protocols (non-peptide).
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
- Studies cited
- 5
- Research grade
- C
- Experience
- 100
- Activity
- 67
Overall check-ins
Trackers & reports
Overview
About CDP-Choline
Choline donor and nootropic compound used for cognitive and neuro-support protocols (non-peptide).
- Category
- Neurological & Cognitive
- Regulatory status
- Supplement / Drug (region-dependent)
- Also known as
- Citicoline
- Self-reports
- 6
Community
What 6 users report
6 community reports
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 100% · Mixed 0% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Cognition
6
Self-reported dose per injection
Median bucket: 2+ mg · Most common: 2+ mg
Reports span 2 to ≥ 2 mg (open-ended top bucket)
2+ mg
6
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
Research
Cited research (4)
Source
PubMed
Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT)
Zafonte et al., 2012
ClinicalTrials.gov
International Citicoline Trial on Acute Stroke (ICTUS) (NCT00331890)
ClinicalTrials.gov, 2006
ClinicalTrials.gov
Citicoline Brain Injury Treatment Trial (COBRIT) (NCT00545662)
ClinicalTrials.gov, 2007
Tools
Explore more
Explore
More ways to learn about CDP-Choline from observational PeptIQ data.
Compare with
Related peptides
Help
Frequently asked
What do PeptIQ users report about CDP-Choline?
This page summarizes 6 anonymized self-reports from PeptIQ users who track CDP-Choline, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
How do side effects relate to overall experience for CDP-Choline?
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
What research is cited for CDP-Choline?
4 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
Is CDP-Choline safe to use?
This wiki does not assess safety or recommend use. CDP-Choline is listed as Supplement / Drug (region-dependent). Consult a licensed clinician for personal medical decisions.
What are the purported benefits and uses of CDP-Choline?
This wiki summarizes observational community reports and linked citations for CDP-Choline. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for CDP-Choline for study-level context — not medical advice.
What is the legal status of CDP-Choline?
CDP-Choline is listed in PeptIQ as Supplement / Drug (region-dependent). Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.
What are the known or theoretical side effects and risks of CDP-Choline?
Safety data quality for CDP-Choline varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.
What is the current state of research on CDP-Choline?
This page links 4 indexed sources for CDP-Choline. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.